Skip to main content

Advertisement

ADVERTISEMENT

Volume 3 - Issue 6 - Nov/Dec 2006

Feature

Original Research
09/05/2008
Percutaneous peripheral arterial intervention (PPAI) has emerged as an effective and less invasive alternative to surgery for peripheral arterial disease (PAD), however, data on gender differences in outcome of PPAI, especially in the stent...
Percutaneous peripheral arterial intervention (PPAI) has emerged as an effective and less invasive alternative to surgery for peripheral arterial disease (PAD), however, data on gender differences in outcome of PPAI, especially in the stent...
Percutaneous peripheral arterial...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
In this study, a canine model of AAA was used to compare intra-aneurysmal pressure and thrombus formation after exclusion with Dacron and ePTFE stent grafts.
In this study, a canine model of AAA was used to compare intra-aneurysmal pressure and thrombus formation after exclusion with Dacron and ePTFE stent grafts.
In this study, a canine model of...
09/05/2008
Vascular Disease Management
Review
09/05/2008
Significant advances in the management of AAA have been made in the last decade, including the introduction of new endovascular treatment modalities (EVAR), screening studies and randomized trials to refine the appropriate timing of...
Significant advances in the management of AAA have been made in the last decade, including the introduction of new endovascular treatment modalities (EVAR), screening studies and randomized trials to refine the appropriate timing of...
Significant advances in the...
09/05/2008
Vascular Disease Management
Case Series
09/05/2008
Nitinol stents have proven to be useful and safe, but imperfect, tools for treating claudication and limb-threatening ischemia. Primary and secondary patency in superficial femoral artery (SFA) occlusions treated with nitinol stents are up to...
Nitinol stents have proven to be useful and safe, but imperfect, tools for treating claudication and limb-threatening ischemia. Primary and secondary patency in superficial femoral artery (SFA) occlusions treated with nitinol stents are up to...
Nitinol stents have proven to be...
09/05/2008
Vascular Disease Management
Review
09/05/2008
The prevalence of peripheral arterial disease (PAD) in the adult population is as high as 12–18%. Conservative treatments, including risk factor modification, supervised exercise training and medical therapy are indicated in patients whose...
The prevalence of peripheral arterial disease (PAD) in the adult population is as high as 12–18%. Conservative treatments, including risk factor modification, supervised exercise training and medical therapy are indicated in patients whose...
The prevalence of peripheral...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
The use of vascular closure devices has dramatically increased in recent years in an attempt to reduce access site complications, patient discomfort and duration of immobilization. Three FDA-approved devices are currently available -...
The use of vascular closure devices has dramatically increased in recent years in an attempt to reduce access site complications, patient discomfort and duration of immobilization. Three FDA-approved devices are currently available -...
The use of vascular closure...
09/05/2008
Vascular Disease Management

Insights

Interview
09/05/2008
What is the value of a comprehensive clinical program for the treatment of carotid artery disease?
What is the value of a comprehensive clinical program for the treatment of carotid artery disease?
What is the value of a...
09/05/2008
Vascular Disease Management

Column

Editor's Corner
09/05/2008

Frank J. Criado, MD

Frank J. Criado, MD
I must say it was heartening to hear the many nice comments on my last Editor’s Corner in the September/October issue. And while wanting to believe such reactions were prompted by my sharp pen and lofty writing… I know better than that!...
I must say it was heartening to hear the many nice comments on my last Editor’s Corner in the September/October issue. And while wanting to believe such reactions were prompted by my sharp pen and lofty writing… I know better than that!...
I must say it was heartening to...
09/05/2008
Vascular Disease Management

Advertisement

Advertisement

Advertisement